1. Home
  2. BMR vs BYSI Comparison

BMR vs BYSI Comparison

Compare BMR & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beamr Imaging Ltd.

BMR

Beamr Imaging Ltd.

HOLD

Current Price

$1.97

Market Cap

47.4M

Sector

Technology

ML Signal

HOLD

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

HOLD

Current Price

$1.87

Market Cap

79.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMR
BYSI
Founded
2009
2010
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.4M
79.0M
IPO Year
2023
2017

Fundamental Metrics

Financial Performance
Metric
BMR
BYSI
Price
$1.97
$1.87
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
84.9K
718.4K
Earning Date
08-13-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,131,000.00
N/A
Revenue This Year
$21.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.96
N/A
52 Week Low
$1.86
$0.98
52 Week High
$6.59
$3.44

Technical Indicators

Market Signals
Indicator
BMR
BYSI
Relative Strength Index (RSI) 41.22 47.95
Support Level $1.89 $1.82
Resistance Level $2.10 $2.40
Average True Range (ATR) 0.15 0.24
MACD -0.02 -0.01
Stochastic Oscillator 16.13 29.25

Price Performance

Historical Comparison
BMR
BYSI

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.

Share on Social Networks: